The Patent Finder

Terms ending in 2030

The Institut Pasteur

Every in-force patent on The Institut Pasteur's record whose computed term ends in 2030, whoever holds it now. Soonest term end first, then patent number.
PatentTitleHolderStatusExpiresConfidence
US 8,450,076Monitoring and Inhibiting Human Immunodeficiency Virus Infection by Modulating HMGB1 Dependent Triggering of HIV-1 Replication and Persistence
In force
 · High confidence
Institut PasteurIn forceHigh confidence
US 9,023,643Medicaments and Methods for Treating Mesothelioma
In force
 · High confidence
Centre National de la Recherche ScientifiqueIn forceHigh confidence
US 9,249,194Neuron Generation, Regeneration and Protection
In force
 · High confidence
Institut Pasteur and Thomas Jefferson UniversityIn forceHigh confidence
US 9,439,404Boosting Human Dendritic Cell Development, Homeostasis and Function in Xenografted Immunodeficient Mice
In force
 · High confidence
Inserm (Institut National de la Santé et de la Recherche Médicale) and Institut PasteurIn forceHigh confidence
US 10,961,536ADAM12 Inhibitors and Their Use Against Inflammation-Induced Fibrosis
In force
 · Medium confidence
Institut PasteurIn forceMedium confidence
US 9,777,276ADAM12 Inhibitors and Their Use Against Inflammation-Induced Fibrosis
In force
 · Medium confidence
Institut PasteurIn forceMedium confidence
US 8,821,851Inflammation-Inhibitory Serum Factors and Uses Thereof
In force
 · High confidence
The General Hospital CorporationIn forceHigh confidence
US 8,980,634Reverse Genetics of Negative-Strand RNA Viruses in Yeast
In force
 · High confidence
Institut Pasteur and Centre National de la Recherche ScientifiqueIn forceHigh confidence
US 8,889,827Opiorphin Peptide Derivatives as Potent Inhibitors of Enkephalin-Degrading Ectopeptidases
In force
 · High confidence
Institut PasteurIn forceHigh confidence
9 of 9 patents shown. Soonest term end first, then patent number.
7 of these are in force and held by The Institut Pasteur.
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited